ANGLE plc

Ongoing website management for ANGLE plc. Working with both the Finance and Marketing stakeholders.

34%
increase in total users
20%
increase in sessions

SoBold have been working with ANGLE plc since 2017 managing and building out their website.

As ANGLE have evolved as a business, SoBold have continued to adapt and improve the website to ensure their messaging reaches the relevant audiences.

Both the Investor and Pharma sides of ANGLE plc have very different business goals with the website.

Managing this relationship with a tailored approach is key to the success of the website management.

SoBold works with the ANGLE investor side of the business on our ‘Maintain’ website management package. This gives them a bank of development support hours that can be used to update the Investor Relations centre.

SoBold work with the ANGLE Marketing team on our ‘Scale’ website management package. We provide monthly design and development sprints which enable us together to build new features, launch new products and scale the website.

A visual identity that speaks to two audiences at once

ANGLE plc sits at the intersection of two very different worlds, the precision and regulatory rigour expected by scientific and pharma audiences, and the clarity and confidence investors look for from an AIM-listed company.

SoBold has maintained a visual language that holds both together: a clean, clinical restraint that suits the science, paired with the structured, data-forward presentation investors expect from price-sensitive updates and financial reporting. As ANGLE’s positioning has evolved, including through the recent rename to CellBxHealth, that visual consistency has helped carry the brand through change without losing trust on either side.

Communication that never drops

The key to our great relationship with ANGLE has been underpinned by communication. Both sides of their business work extremely closely with SoBold and we act as their digital team.

12%


increase in events per session

ANGLE have clear conflicting audiences, in both the Pharma and Investor side of their business.

Content sorting and tagging, a clear Investor Relations mega menu, and consistent calls-to-action for the relevant target audiences has been key to achieving this distinction.

Working with an AIM listed company means that there are updates required to the website at very short notice and out of hours.

The ANGLE team always make us aware in advance, and SoBold’s round-the-clock support means we are able to help with time sensitive requests.

ANGLE’s marketing team are regularly attending events and short on time to brief SoBold on upcoming website updates.

Our Project Managers work closely and flexibly with their team and where we have not been shared specific features to work on, we are able to go through the backlog of tasks in our project management tool, ClickUp.

The key to our great relationship with ANGLE has been underpinned by communication.

Both sides of their business work extremely closely with SoBold and we act as their digital team.

We worked with ANGLE on a recent name change from ANGLE plc to CellBxHealth plc.

The new name reflects a clearer strategic focus on CTC intelligence and high value CTC based precision diagnostic testing.

We implemented the repositioning across the website, ensuring consistency across all messaging, page titles and references.

The priority was accuracy and continuity. We carefully managed updates to protect SEO value and ensure a smooth transition for investors, partners and scientific users.

Beyond the launch

SoBold’s ongoing work with ANGLE plc extends well beyond the original build, evolving alongside the business as its scientific positioning and site structure develop.

Recent work has included expanding the site’s scientific content to better support ANGLE’s positioning, with new pages covering Discover Liquid Biopsy, Discover Circulating Tumour Cells, Parsortix Platform, Androgen Receptor, DNA Damage Response, PCR, and Xenograft, alongside a new Overview page presenting key statistics and performance data for the Parsortix platform.

/ 2

Testimonials

70% Year on year increase in engaged sessions
View case study

We have been working with SoBold since 2018, managing and building out our website. Our website has continued to scale with SoBold and has become a valuable asset for both our Investor and Pharma services audiences. Being an AIM-listed company, we also have price-sensitive updates that need to often be published at short notice and out of hours, and SoBold has always been responsive and accurate in managing these requests.

Ian Griffiths Chief Financial Officer

Similar work

Working with SoBold since: 2022

Website Design and Development for Australasia's largest health IT network.

1.8s
Mobile load time

Let’s scope your next project.

Whether you’re in financial services, healthcare, energy or another sector, we start every project with a conversation about your requirements. No commitment, just a discussion about your needs.

Schedule a consultation